Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials.
Study Design
- Loại nghiên cứu
- Meta-Analysis
- Đối tượng nghiên cứu
- Healthy or constipated adults
- Can thiệp
- Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. None
- Đối chứng
- Control/placebo
- Kết quả chính
- Intestinal transit time
- Xu hướng hiệu quả
- Positive
- Nguy cơ sai lệch
- Moderate
Abstract
AIM: To determine the efficacy of probiotic supplementation on intestinal transit time (ITT) and to identify factors that influence these outcomes. METHODS: A systematic review of randomized controlled trials (RCTs) of probiotic supplementation that measured ITT in adults was conducted by searching MEDLINE and EMBASE using relevant key word combinations. Main search limits included RCTs of probiotic supplementation in healthy or constipated adults that measured ITT. Study quality was assessed using the Jadad scale. A random effects meta-analysis was performed with standardized mean difference (SMD) of ITT between probiotic and control groups as the primary outcome. Meta-regression and subgroup analyses were conducted to examine the impact of moderator variables on ITT SMD. RESULTS: A total of 11 clinical trials with 13 treatment effects representing 464 subjects were included in this analysis. Probiotic supplementation was associated with decreased ITT in relation to controls, with an SMD of 0.40 (95%CI: 0.20-0.59, P < 0.001). Constipation (r (2) = 39%, P = 0.01), higher mean age (r (2) = 27%, P = 0.03), and higher percentage of female subjects (r (2) = 23%, P < 0.05) were predictive of decreased ITT with probiotics in meta-regression. Subgroup analyses demonstrated statistically greater reductions in ITT with probiotics in subjects with vs without constipation and in older vs younger subjects [both SMD: 0.59 (95%CI: 0.39-0.79) vs 0.17 (95%CI: -0.08-0.42), P = 0.01]. Medium to large treatment effects were identified with Bifidobacterium Lactis (B. lactis) HN019 (SMD: 0.72, 95%CI: 0.27-1.18, P < 0.01) and B. lactis DN-173 010 (SMD: 0.54, 95%CI: 0.15-0.94, P < 0.01) while other single strains and combination products yielded small treatment effects. CONCLUSION: Overall, short-term probiotic supplementation decreases ITT with consistently greater treatment effects identified in constipated or older adults and with certain probiotic strains.
Tóm lược
Overall, short-term probiotic supplementation decreases ITT with consistently greater treatment effects identified in constipated or older adults and with certain probiotic strains.
Used In Evidence Reviews
Similar Papers
Alimentary pharmacology & therapeutics · 2009
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation.
The American journal of clinical nutrition · 2014
The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.
World journal of gastroenterology · 2010
Systematic review of randomised controlled trials: probiotics for functional constipation.
Scandinavian journal of gastroenterology · 2011
Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults.
World journal of gastroenterology · 2008
Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women.
Journal of clinical gastroenterology · 2011